Evaluation of taranabant (MK-0364) for its self-administration in rhesus monkeys and for its discriminative stimulus effects in rats-Reference-Cited by-同舟云学术

Evaluation of taranabant (MK-0364) for its self-administration in rhesus monkeys and for its discriminative stimulus effects in rats

Published:2009-12 Issue:8 Volume:70 Page:577-584
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Beardsley Patrick M.

Publisher

Wiley

Subject

Drug Discovery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ddr.20336/fullpdf

Reference22 articles.

1. The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake;Addy;Cell Metab,2008

2. Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function;Alonso;Neuroscience,1999

3. Rimonabant: suicide and depression. Depression and suicidal tendencies are about twice as frequent with rimonabant as with placebo;Anonymous;Prescrire Int,2007

4. Principles of drug abuse liability assessment in laboratory animals;Ator;Drug Alcohol Depend,2003

5. Drug abuse potential evaluation in animals;Balster;Br J Addict,1991

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the abuse potential of AM281, a new synthetic cannabinoid CB1 receptor antagonist;European Journal of Pharmacology;2015-11

2. Human Abuse Potential and Cognitive Effects of Taranabant, a Cannabinoid 1 Receptor Inverse Agonist;Journal of Clinical Psychopharmacology;2012-08

3. Perceptual Drug Discriminative Aspects of the Endocannabinoid Signaling System in Animals And Man;Drug Discrimination;2011-10-24